查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1301163

醫療保健合同研究所市場規模、份額和趨勢分析報告：按類型、按服務、按地區、細分趨勢：2023-2030

Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Services (Clinical Monitoring, Data Management), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

醫療保健合同研究機構市場增長和趨勢

Grand View Research, Inc.的最新報告顯示，到 2030 年，全球醫療保健合同研究組織市場規模預計將達到 805 億美元，2023 年至 2030 年復合年增長率為 7.8%。

預計藥物開發成本的增加將在預測期內推動市場需求。不斷上升的臨床試驗成本和患者招募挑戰也促使生物製藥公司將目光投向中歐和東歐、亞太地區、拉丁美洲和中東等地區，以降低成本並加快患者招募。

此外，行業參與者在緊迫的時間安排上面臨的壓力越來越大，這增加了將研究活動外包給 CRO 的需求。一些政府機構還外包臨床試驗活動，以便利用必要的基礎設施和專業知識進行臨床試驗，並最大限度地減少成本和時間表。

受疫情影響，臨床試驗中心關閉，CRO市場暫時受到影響。然而，由於對治療的需求量很大，臨床試驗中心已經重新開放，但需要採取一定的措施和預防措施，以避免病毒傳播。此外，全球對冠狀病毒疫苗的關注對 COVID-19 疫苗和藥物的開發產生了重大影響。預計這將對市場產生積極影響。

過去五年，併購交易數量大幅增加。從2016年到2023年，我們見證了多起大型併購。此外，大型交易的趨勢將在 2021 年及以後回升，例如 M&B Sciences Inc. 於 2022 年 3 月收購 Clara Health，擴大了 M&B Sciences 基於數字技術的臨床試驗的範圍。此外，2021年12月，Thermo Fisher宣布收購製藥服務巨頭PPD，2021年2月，ICON plc宣布收購PRA Health Sciences。生物製藥服務領域使用的分析技術和軟件解決方案已經進入整合時代。因此，上述因素支撐了市場的增長。

醫療保健合同研究所市場報告亮點

  • 從類型來看，臨床細分市場將在2022年主導全球醫療保健CRO市場，佔據最大份額，達到76.2%。因為臨床領域由四個涉及主題的複雜階段組成。對新療法的強勁需求進一步促進了該領域的增長。
  • 在服務中，臨床監測領域在 2022 年擁有最大的市場份額，達到 20.2%。
  • 由於多家全球公司將大部分收入投資於研究活動，北美在 2022 年佔據了 24.8% 的巨大市場份額。
  • 由於與西方國家相比成本較低，預計亞太地區在預測期內將增長 9.5%。
  • 由於該疾病的高患病率，預計中國、日本和印度的合同研究組織市場將出現顯著增長。

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
    • 段定義
    • 類型
    • 服務
  • 區域範圍
  • 估計/預測時間表
  • 目的
    • 目標1
    • 目標2
    • 目標 3
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
  • 信息或數據分析
    • 數據分析模型
  • 市場形成和驗證
  • 型號詳情
    • 產品流向分析
    • 母市場分析
  • 二級信息列表
  • 縮略語表

第二章執行摘要

  • 市場展望
  • 分部展望
  • 競爭考慮

3.醫療保健合同研究組織市場變量、趨勢和範圍

  • 市場譜系展望
    • 母公司市場展望
    • 相關/補充市場展望
  • 市場動態
    • 市場驅動力分析
    • 市場約束因素分析
  • 醫療保健合同研究所市場分析工具
    • 行業分析 - 搬運工
    • PESTEL 分析
    • COVID-19 的影響分析

第四章醫療合同研究機構市場：按類型估計和趨勢分析

  • 醫療保健合同研究組織市場，按類型：細分儀表板
  • 醫療保健合同研究組織市場，按類型：變化分析
    • 藥物發現
    • 臨床前
    • 臨床

第五章醫療合同研究機構市場：按服務分類的估計和趨勢分析

  • 醫療保健合同研究組織市場，按服務：細分儀表板
  • 醫療保健合同研究組織市場，按服務分類：變化分析
    • 項目管理/臨床供應管理
    • 數據管理
    • 監管/醫療
    • 醫學寫作
    • 臨床監測
    • 質量控制/保證
    • 生物統計學
    • 支付給調查員的費用
    • 實驗室
    • 患者和設施招募
    • 技術
    • 其他

第六章 醫療合同研究機構市場：按地區估算及趨勢分析

  • 2022 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 全球區域市場快照
  • 北美
    • 2018-2030 年市場估算和預測（收入，百萬美元）
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 瑞士
    • 比利時
    • 荷蘭
    • 奧地利
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳大利亞
    • 泰國
    • 台灣
    • 印度尼西亞
    • 馬來西亞
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
  • 中東和北非
    • 埃及
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 伊朗
    • 以色列
  • 世界其他地區
    • 南非

第7章 競爭格局

  • 市場進入者分類
    • 創新者
    • 市場領導者
    • 啟動
    • 2022 年公司市場份額分析
  • 公司簡介
    • ICON Plc
    • Charles River Laboratories
    • Syneos Health
    • IQVIA Inc
    • GVK Biosciences Private Limited
    • Laboratory Corporation of America Holdings
    • Thermo Fisher Scientific Inc.
    • Parexel International Corporation
    • Medidata Solutions, Inc
    • Pharmaron GMBH.
    • SGS SA
    • KCR SA
    • CTI Clinical Trial &Consulting
    • PSI
    • Worldwide Clinical Trials
    • Wuxi AppTec
    • Advanced Clinical
    • Caidya
Product Code: 978-1-68038-688-2

Healthcare Contract Research Organization Market Growth & Trends

The global healthcare contract research organization market size is expected to reach USD 80.5 billion by 2030 and is projected to expand at a CAGR of 7.8% from 2023 to 2030, according to a new report by Grand View Research, Inc. The increasing cost of drug development is expected to drive market demand over the forecast period. Also, rising clinical trials cost and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and the Middle East for cost savings and quick patient recruitment.

In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing research activities to contract research organizations(CRO)s. Some government organizations are also outsourcing their clinical trial activities so that they can carry out clinical trials with the required infrastructure and expertise and minimize their cost and timelines.

The CRO market was temporarily affected by the ongoing pandemic, as it led to the closure of clinical trial sites. However, owing to the significant demand for treatments, the clinical trial sites were reopened with certain measures and precautions to avoid the spread of the virus. Moreover, the worldwide focus on finding a vaccine against coronavirus has had a significant impact on the development of vaccines & drugs for COVID-19. This is expected to have a positive impact on the market.

Over the past 5 years, the number of mergers and acquisitions significantly increased. Several large mergers have been witnessed since 2016 till 2023. Moreover, the trend of large transactions seems to be picking up since 2021, as in March 2022, M&B Sciences Inc, acquired Clara Health, which expanded M&B Sciences' access to digital technology-based clinical trials. Moreover, in December 2021, Thermo Fisher announced the acquisition of pharmaceutical services giant PPD, and in February 2021, ICON plc announced the acquisition of PRA Health Sciences. An era of consolidation has been witnessed around analytical technologies and software solutions used in the biopharmaceutical and pharmaceutical companies' services space. Hence, the aforementioned factors supported the market's growth.

Healthcare Contract Research Organization Market Report Highlights

  • Based on type, the clinical segment has dominated the global healthcare CRO market in 2022, with the largest share of 76.2% owing to the fact that it comprises four elaborate phases, including human subjects. The significant demand for new treatments has further contributed to the growth of the segment
  • Among services, the clinical monitoring segment was the largest in terms of market share at 20.2% in 2022
  • North America held a significant market share of 24.8% in 2022 due to the presence of several global players who invest a major part of their revenue in research activities
  • Asia Pacific is anticipated to witness lucrative growth of 9.5% over the forecast period due to the reduced cost it offers in comparison to the western economies
  • China, Japan, and India are projected to witness tremendous growth in the contract research organization market owing to high disease prevalence

Table of content

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
    • 1.1.2. Type
    • 1.1.3. Service
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective-1
    • 1.4.2. Objective-2
    • 1.4.3. Objective-3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. Parent Market Analysis
  • 1.10. List Of Secondary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Healthcare Contract Research Organization Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Rate of Clinical Research To Boost Demand For Outsourcing Services
      • 3.2.1.2. Increasing Adoption Of Advanced Technologies
      • 3.2.1.3. Increasing Mergers and Collaborations
      • 3.2.1.4. Increasing Demand For Outsourcing Services Across The Developing Economies
      • 3.2.1.5. Patent Cliff
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Quality issues of CRO services
      • 3.2.2.2. Intellectual property rights issues
  • 3.3. Healthcare Contract Research Organization Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat Of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Healthcare Contract Research Organization Market: Type Estimates & Trend Analysis

  • 4.1. Healthcare Contract Research Organization Market, By Type: Segment Dashboard
  • 4.2. Healthcare Contract Research Organization Market, By Type: Movement Analysis
  • 4.3. Healthcare Contract Research Organization Market Estimates & Forecasts, By Type, 2018 - 2030
    • 4.3.1. Drug Discovery
      • 4.3.1.1. Drug Discovery Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
      • 4.3.1.2. Target Validation
      • 4.3.1.2.1. Target Validation Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
      • 4.3.1.3. Lead Identification
      • 4.3.1.3.1. Lead Identification Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
      • 4.3.1.4. Lead Optimization
      • 4.3.1.4.1. Lead Optimization Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 4.3.2. Pre-clinical
      • 4.3.2.1. Pre-clinical Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 4.3.3. Clinical
      • 4.3.3.1. Clinical Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
      • 4.3.3.2. Phase I Trial Services
      • 4.3.3.2.1. Phase I Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
      • 4.3.3.3. Phase II Trial Services
      • 4.3.3.3.1. Phase II Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
      • 4.3.3.4. Phase III Trial Services
      • 4.3.3.4.1. Phase III Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
      • 4.3.3.5. Phase IV Trial Services
      • 4.3.3.5.1. Phase IV Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)

Chapter 5. Healthcare Contract Research Organization Market: Services Estimates & Trend Analysis

  • 5.1. Healthcare Contract Research Organization Market, By Services: Segment Dashboard
  • 5.2. Healthcare Contract Research Organization Market, By Services: Movement Analysis
  • 5.3. Healthcare Contract Research Organization Market Estimates & Forecasts, By Services, 2018 - 2030
    • 5.3.1. Project Management/Clinical Supply Management
      • 5.3.1.1. Project Management/Clinical Supply Management Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.2. Data Management
      • 5.3.2.1. Data Management Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.3. Regulatory/Medical Affairs
      • 5.3.3.1. Regulatory/Medical Affairs Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.4. Medical Writing
      • 5.3.4.1. Medical Writing Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.5. Clinical Monitoring
      • 5.3.5.1. Clinical Monitoring Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.6. Quality Management/Assurance
      • 5.3.6.1. Quality Management/Assurance Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.7. Bio-statistics
      • 5.3.7.1. Bio-statistics Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.8. Investigator Payments
      • 5.3.8.1. Investigator Payments Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.9. Laboratory
      • 5.3.9.1. Laboratory Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.10. Patient and Site Recruitment
      • 5.3.10.1. Patient and Site Recruitment Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.11. Technology
      • 5.3.11.1. Technology Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.12. Others
      • 5.3.12.1. Others Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)

Chapter 6. Healthcare Contract Research Organization Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2022 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. North America
    • 6.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Competitive Scenario
      • 6.5.1.3. Regulatory Framework
      • 6.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
    • 6.5.2. Germany
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
    • 6.5.3. France
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
    • 6.5.4. Italy
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
    • 6.5.5. Spain
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
    • 6.5.6. Switzerland
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Switzerland Market Estimates and Forecasts, 2018 - 2030
    • 6.5.7. Belgium
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Belgium Market Estimates and Forecasts, 2018 - 2030
    • 6.5.8. Netherlands
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Netherlands Market Estimates and Forecasts, 2018 - 2030
    • 6.5.9. Austria
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Competitive Scenario
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Austria Market Estimates and Forecasts, 2018 - 2030
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key Country Dynamics
      • 6.6.1.2. Competitive Scenario
      • 6.6.1.3. Regulatory Framework
      • 6.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
    • 6.6.2. India
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
    • 6.6.4. South Korea
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
    • 6.6.6. Thailand
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
    • 6.6.7. Taiwan
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Taiwan Market Estimates and Forecasts, 2018 - 2030
    • 6.6.8. Indonesia
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Competitive Scenario
      • 6.6.8.3. Regulatory Framework
      • 6.6.8.4. Indonesia Market Estimates and Forecasts, 2018 - 2030
    • 6.6.9. Malaysia
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Competitive Scenario
      • 6.6.9.3. Regulatory Framework
      • 6.6.9.4. Malaysia Market Estimates and Forecasts, 2018 - 2030
    • 6.6.10. Singapore
      • 6.6.10.1. Key Country Dynamics
      • 6.6.10.2. Competitive Scenario
      • 6.6.10.3. Regulatory Framework
      • 6.6.10.4. Singapore Market Estimates and Forecasts, 2018 - 2030
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Competitive Scenario
      • 6.7.1.3. Regulatory Framework
      • 6.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 6.7.2. Mexico
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
    • 6.7.4. Colombia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
    • 6.7.5. Chile
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030
  • 6.8. Middle East & North Africa
    • 6.8.1. Egypt
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Competitive Scenario
      • 6.8.1.3. Regulatory Framework
      • 6.8.1.4. Egypt Market Estimates and Forecasts, 2018 - 2030
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 6.8.3. UAE
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
    • 6.8.4. Iran
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Iran Market Estimates and Forecasts, 2018 - 2030
    • 6.8.5. Israel
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Israel Market Estimates and Forecasts, 2018 - 2030
  • 6.9. Rest of the World
    • 6.9.1. South Africa
      • 6.9.1.1. Key Country Dynamics
      • 6.9.1.2. Competitive Scenario
      • 6.9.1.3. Regulatory Framework
      • 6.9.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
    • 7.1.1. Innovators
    • 7.1.2. Market Leaders
    • 7.1.3. Emerging Players
    • 7.1.4. Company Market Share Analysis, 2022
  • 7.2. Company Profiles
    • 7.2.1. ICON Plc
      • 7.2.1.1. Company Overview
      • 7.2.1.2. Financial Performance
      • 7.2.1.3. Service Benchmarking
      • 7.2.1.4. Strategic Initiatives
    • 7.2.2. Charles River Laboratories
      • 7.2.2.1. Company Overview
      • 7.2.2.2. Financial Performance
      • 7.2.2.3. Service Benchmarking
      • 7.2.2.4. Strategic Initiatives
    • 7.2.3. Syneos Health
      • 7.2.3.1. Company Overview
      • 7.2.3.2. Financial Performance
      • 7.2.3.3. Service Benchmarking
      • 7.2.3.4. Strategic Initiatives
    • 7.2.4. IQVIA Inc
      • 7.2.4.1. Company Overview
      • 7.2.4.2. Financial Performance
      • 7.2.4.3. Service Benchmarking
      • 7.2.4.4. Strategic Initiatives
    • 7.2.5. GVK Biosciences Private Limited
      • 7.2.5.1. Company Overview
      • 7.2.5.2. Financial Performance
      • 7.2.5.3. Service Benchmarking
      • 7.2.5.4. Strategic Initiatives
    • 7.2.6. Laboratory Corporation of America Holdings
      • 7.2.6.1. Company Overview
      • 7.2.6.2. Financial Performance
      • 7.2.6.3. Service Benchmarking
      • 7.2.6.4. Strategic Initiatives
    • 7.2.7. Thermo Fisher Scientific Inc.
      • 7.2.7.1. Company Overview
      • 7.2.7.2. Financial Performance
      • 7.2.7.3. Service Benchmarking
      • 7.2.7.4. Strategic Initiatives
    • 7.2.8. Parexel International Corporation
      • 7.2.8.1. Company Overview
      • 7.2.8.2. Financial Performance
      • 7.2.8.3. Service Benchmarking
      • 7.2.8.4. Strategic Initiatives
    • 7.2.9. Medidata Solutions, Inc
      • 7.2.9.1. Company Overview
      • 7.2.9.2. Financial Performance
      • 7.2.9.3. Service Benchmarking
      • 7.2.9.4. Strategic Initiatives
    • 7.2.10. Pharmaron GMBH.
      • 7.2.10.1. Company Overview
      • 7.2.10.2. Financial Performance
      • 7.2.10.3. Service Benchmarking
      • 7.2.10.4. Strategic Initiatives
    • 7.2.11. SGS SA
      • 7.2.11.1. Company Overview
      • 7.2.11.2. Financial Performance
      • 7.2.11.3. Service Benchmarking
      • 7.2.11.4. Strategic Initiatives
    • 7.2.12. KCR S.A.
      • 7.2.12.1. Company Overview
      • 7.2.12.2. Financial Performance
      • 7.2.12.3. Service Benchmarking
      • 7.2.12.4. Strategic Initiatives
    • 7.2.13. CTI Clinical Trial & Consulting
      • 7.2.13.1. Company Overview
      • 7.2.13.2. Financial Performance
      • 7.2.13.3. Service Benchmarking
      • 7.2.13.4. Strategic Initiatives
    • 7.2.14. PSI
      • 7.2.14.1. Company Overview
      • 7.2.14.2. Financial Performance
      • 7.2.14.3. Service Benchmarking
      • 7.2.14.4. Strategic Initiatives
    • 7.2.15. Worldwide Clinical Trials
      • 7.2.15.1. Company Overview
      • 7.2.15.2. Financial Performance
      • 7.2.15.3. Service Benchmarking
      • 7.2.15.4. Strategic Initiatives
    • 7.2.16. Wuxi AppTec
      • 7.2.16.1. Company Overview
      • 7.2.16.2. Financial Performance
      • 7.2.16.3. Service Benchmarking
      • 7.2.16.4. Strategic Initiatives
    • 7.2.17. Advanced Clinical
      • 7.2.17.1. Company Overview
      • 7.2.17.2. Financial Performance
      • 7.2.17.3. Service Benchmarking
      • 7.2.17.4. Strategic Initiatives
    • 7.2.18. Caidya
      • 7.2.18.1. Company Overview
      • 7.2.18.2. Financial Performance
      • 7.2.18.3. Service Benchmarking
      • 7.2.18.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Healthcare Contract Research Outsourcing Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 5 Global Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 6 Global Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 7 Global Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 8 North America Healthcare Contract Research Outsourcing Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 North America Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 11 North America Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 12 North America Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 13 U.S. Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 15 U.S. Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 16 U.S. Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 17 Canada Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 19 Canada Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 20 Canada Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 21 Europe Healthcare Contract Research Outsourcing Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 24 Europe Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 25 Europe Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 26 UK Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 UK Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 28 UK Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 29 UK Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 30 Germany Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 Germany Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 32 Germany Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 33 Germany Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 34 France Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 France Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 36 France Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 37 France Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 38 Italy Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 40 Italy Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 41 Italy Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 42 Spain Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Spain Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 44 Spain Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 45 Spain Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 46 Switzerland Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Switzerland Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 48 Switzerland Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 49 Switzerland Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 50 Belgium Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Belgium Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 52 Belgium Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 53 Belgium Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 54 Netherlands Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Netherlands Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 56 Netherlands Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 57 Netherlands Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 58 Austria Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 Austria Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 60 Austria Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 61 Austria Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Healthcare Contract Research Outsourcing Market, by Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 67 India Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 India Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 69 India Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 70 India Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 71 China Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 China Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 73 China Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 74 China Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 75 Japan Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 Japan Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 77 Japan Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 78 Japan Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 79 South Korea Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 South Korea Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 81 South Korea Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 82 South Korea Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 83 Taiwan Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 84 Taiwan Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 85 Taiwan Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 86 Taiwan Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 87 Australia Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 Australia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 89 Australia Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 90 Australia Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 91 Indonesia Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 92 Indonesia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 93 Indonesia Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 94 Indonesia Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 95 Malaysia Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 96 Malaysia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 97 Malaysia Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 98 Malaysia Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 99 Singapore Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 100 Singapore Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 101 Singapore Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 102 Singapore Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 103 Thailand Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 104 Thailand Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 105 Thailand Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 106 Thailand Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 107 Latin America Healthcare Contract Research Outsourcing Market, by Country, 2018 - 2030 (USD Million)
  • Table 108 Latin America Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 109 Latin America Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 110 Latin America Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 111 Latin America Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 112 Brazil Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 113 Brazil Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 114 Brazil Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 115 Brazil Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 116 Mexico Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 117 Mexico Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 118 Mexico Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 119 Mexico Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 120 Argentina Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 121 Argentina Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 122 Argentina Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 123 Argentina Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 124 Colombia Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 125 Colombia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 126 Colombia Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 127 Colombia Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 128 Chile Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 129 Chile Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 130 Chile Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 131 Chile Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 132 MEA Healthcare Contract Research Outsourcing Market, by Country, 2018 - 2030 (USD Million)
  • Table 133 MEA Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 134 MEA Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 135 MEA Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 136 MEA Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 137 Egypt Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 138 Egypt Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 139 Egypt Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 140 Egypt Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 144 Saudi Arabia Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 145 UAE Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 146 UAE Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 147 UAE Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 148 UAE Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 149 Iran Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 150 Iran Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 151 Iran Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 152 Iran Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 153 Israel Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 154 Israel Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 155 Israel Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 156 Rest Of The World Healthcare Contract Research Outsourcing Market, by Country, 2018 - 2030 (USD Million)
  • Table 157 Rest Of The World Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 158 Rest Of The World Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 159 Rest Of The World Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 160 Rest Of The World Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 161 South Africa Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 162 South Africa Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 163 South Africa Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 164 South Africa Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Parent Market Analysis
  • Fig. 10 Healthcare CRO market snapshot (2022)
  • Fig. 11 Market trends and outlook
  • Fig. 12 Healthcare CRO market segmentation
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Benefits of using robotic labs
  • Fig. 15 Pharmaceutical R&D spending 2020 - 2022 (USD Billion)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Penetration & growth prospect mapping
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 20 Healthcare CRO market stage outlook: Segment dashboard
  • Fig. 21 Healthcare CRO market: Type movement analysis
  • Fig. 22 Drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 23 Target validation market, 2018 - 2030 (USD Million)
  • Fig. 24 Lead identification market, 2018 - 2030 (USD Million)
  • Fig. 25 Lead optimization market, 2018 - 2030 (USD Million)
  • Fig. 26 Pre-clinical market, 2018 - 2030 (USD Million)
  • Fig. 27 Clinical market, 2018 - 2030 (USD Million)
  • Fig. 28 Phase I trial services market, 2018 - 2030 (USD Million)
  • Fig. 29 Phase II trial services market, 2018 - 2030 (USD Million)
  • Fig. 30 Phase III trial services market, 2018 - 2030 (USD Million)
  • Fig. 31 Phase IV trial services market, 2018 - 2030 (USD Million)
  • Fig. 32 Healthcare CRO market Service outlook: Segment dashboard
  • Fig. 33 Healthcare CRO market: Service movement analysis
  • Fig. 34 Parameters for measuring success of provider solution
  • Fig. 35 Project management/clinical supply management market, 2018 - 2030 (USD Million)
  • Fig. 36 Clinical data management flow
  • Fig. 37 Data management market, 2018 - 2030 (USD Million)
  • Fig. 38 Regulatory/medical affairs market, 2018 - 2030 (USD Million)
  • Fig. 39 Medical writing market, 2018 - 2030 (USD Million)
  • Fig. 40 Clinical monitoring market, 2018 - 2030 (USD Million)
  • Fig. 41 Quality management/ assurance market, 2018 - 2030 (USD Million)
  • Fig. 42 Bio-statistics market, 2018 - 2030 (USD Million)
  • Fig. 43 Investigator payments market, 2018 - 2030 (USD Million)
  • Fig. 44 Laboratory market, 2018 - 2030 (USD Million)
  • Fig. 45 Strategic initiatives with positive impact on patient recruitment
  • Fig. 46 Patient and site recruitment market, 2018 - 2030 (USD Million)
  • Fig. 47 Technology services market, 2018 - 2030 (USD Million)
  • Fig. 48 Other services market, 2018 - 2030 (USD Million)
  • Fig. 49 Regional market: Key takeaways
  • Fig. 50 Regional outlook, 2022 & 2030
  • Fig. 51 North America market, 2018 - 2030 (USD Million)
  • Fig. 52 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 53 Canada market, 2018 - 2030 (USD Million)
  • Fig. 54 Europe market, 2018 - 2030 (USD Million)
  • Fig. 55 UK market, 2018 - 2030 (USD Million)
  • Fig. 56 Germany market, 2018 - 2030 (USD Million)
  • Fig. 57 France market, 2018 - 2030 (USD Million)
  • Fig. 58 Italy market, 2018 - 2030 (USD Million)
  • Fig. 59 Spain market, 2018 - 2030 (USD Million)
  • Fig. 60 Switzerland market, 2018 - 2030 (USD Million)
  • Fig. 61 Belgium market, 2018 - 2030 (USD Million)
  • Fig. 62 Netherlands market, 2018 - 2030 (USD Million)
  • Fig. 63 Austria market, 2018 - 2030 (USD Million)
  • Fig. 64 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 65 India market, 2018 - 2030 (USD Million)
  • Fig. 66 China market, 2018 - 2030 (USD Million)
  • Fig. 67 Japan market, 2018 - 2030 (USD Million)
  • Fig. 68 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 69 Taiwan market, 2018 - 2030 (USD Million)
  • Fig. 70 Australia market, 2018 - 2030 (USD Million)
  • Fig. 71 Indonesia market, 2018 - 2030 (USD Million)
  • Fig. 72 Malaysia market, 2018 - 2030 (USD Million)
  • Fig. 73 Singapore market, 2018 - 2030 (USD Million)
  • Fig. 74 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 75 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 76 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 77 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 78 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 79 Colombia market, 2018 - 2030 (USD Million)
  • Fig. 80 Chile market, 2018 - 2030 (USD Million)
  • Fig. 81 Middle East & North Africa market, 2018 - 2030 (USD Million)
  • Fig. 82 Egypt market, 2018 - 2030 (USD Million)
  • Fig. 83 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 84 UAE market, 2018 - 2030 (USD Million)
  • Fig. 85 Iran market, 2018 - 2030 (USD Million)
  • Fig. 86 Israel market, 2018 - 2030 (USD Million)
  • Fig. 87 Rest of the World market, 2018 - 2030 (USD Million)
  • Fig. 88 South Africa market, 2018 - 2030 (USD Million)